# Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank

> **NCT02951416** · — · ACTIVE_NOT_RECRUITING · sponsor: **Andreas Guenther** · enrollment: 2000 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Idiopathic Interstitial Pneumonia
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases

## Interventions

- **OTHER:** patient registry (observation and biomaterial sampling)

## Key facts

- **NCT ID:** NCT02951416
- **Lead sponsor:** Andreas Guenther
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-09
- **Primary completion:** 2025-01
- **Final completion:** 2040-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951416, "Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02951416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*